Pituitary FSH is released by a heterodimer of the beta-subunits from the two forms of inhibin - PubMed (original) (raw)
Comparative Study
. 1986 Jun;321(6072):779-82.
doi: 10.1038/321779a0.
- PMID: 3086749
- DOI: 10.1038/321779a0
Comparative Study
Pituitary FSH is released by a heterodimer of the beta-subunits from the two forms of inhibin
N Ling et al. Nature. 1986 Jun.
Abstract
Inhibin is a gonadal protein that specifically inhibits the secretion of pituitary follicle-stimulating hormone (FSH). Two forms of inhibin (A and B) have been purified from porcine follicular fluid and characterized as heterodimers of relative molecular mass (Mr) 32,000 (ref. 2). Each inhibin is comprised of an identical alpha-subunit of Mr 18,000 and a distinct but related beta-subunit of Mr 13,800-14,700 linked by interchain disulphide bond(s). Throughout the purification of inhibins, we consistently observed two fractions which stimulated the secretion of pituitary FSH. We report here the isolation of one of the FSH-releasing proteins; it has a Mr of 24,000 and its N-terminal sequences up to residue 32 are identical to those of each beta-subunit of inhibins A and B. In the presence of reducing agents, SDS-polyacrylamide gel electrophoresis resolves the FSH-releasing substance into two subunits which are identical in their migration behaviour to the reduced beta-subunits of inhibins A and B. Based on the N-terminal sequence data and Mr of the intact and reduced molecules, we propose that the FSH-releasing substance, which is active in picomolar concentrations, is a heterodimeric protein composed of the two beta-subunits of inhibins A and B linked by interchain disulphide bond(s). The structural organization of the FSH-releasing substance is homologous to that of transforming growth factor-beta (TGF-beta), which also possesses FSH-releasing activity in the same bioassay. We suggest that the substance be called activin to signify the fact that it has opposite biological effects to inhibin.
Similar articles
- Purification and characterization of an FSH releasing protein from porcine ovarian follicular fluid.
Vale W, Rivier J, Vaughan J, McClintock R, Corrigan A, Woo W, Karr D, Spiess J. Vale W, et al. Nature. 1986 Jun 19-25;321(6072):776-9. doi: 10.1038/321776a0. Nature. 1986. PMID: 3012369 - A homodimer of the beta-subunits of inhibin A stimulates the secretion of pituitary follicle stimulating hormone.
Ling N, Ying SY, Ueno N, Shimasaki S, Esch F, Hotta M, Guillemin R. Ling N, et al. Biochem Biophys Res Commun. 1986 Aug 14;138(3):1129-37. doi: 10.1016/s0006-291x(86)80400-4. Biochem Biophys Res Commun. 1986. PMID: 3092817 - Inhibins, activins and follistatins.
Ying SY. Ying SY. J Steroid Biochem. 1989 Oct;33(4B):705-13. J Steroid Biochem. 1989. PMID: 2689779 Review. - Purification and characterization of high molecular weight forms of inhibin from bovine follicular fluid.
Sugino K, Nakamura T, Takio K, Miyamoto K, Hasegawa Y, Igarashi M, Titani K, Sugino H. Sugino K, et al. Endocrinology. 1992 Feb;130(2):789-96. doi: 10.1210/endo.130.2.1733725. Endocrinology. 1992. PMID: 1733725 - Inhibins, activins, and follistatins: gonadal proteins modulating the secretion of follicle-stimulating hormone.
Ying SY. Ying SY. Endocr Rev. 1988 May;9(2):267-93. doi: 10.1210/edrv-9-2-267. Endocr Rev. 1988. PMID: 3136011 Review.
Cited by
- DNA methylation and histone modifications are associated with repression of the inhibin α promoter in the rat corpus luteum.
Meldi KM, Gaconnet GA, Mayo KE. Meldi KM, et al. Endocrinology. 2012 Oct;153(10):4905-17. doi: 10.1210/en.2012-1292. Epub 2012 Aug 3. Endocrinology. 2012. PMID: 22865368 Free PMC article. - Transforming growth factor-beta: possible roles in carcinogenesis.
Roberts AB, Thompson NL, Heine U, Flanders C, Sporn MB. Roberts AB, et al. Br J Cancer. 1988 Jun;57(6):594-600. doi: 10.1038/bjc.1988.135. Br J Cancer. 1988. PMID: 3044431 Free PMC article. Review. - Localization of Activin A/EDF in the Normal and Diabetic Rat Pancreas: Immunohistochemical and In Situ Hybridization Studies.
Ide M, Shintani Y, Kosaka M, Sano T, Saito S. Ide M, et al. Endocr Pathol. 1996 Autumn;7(3):229-236. doi: 10.1007/BF02739926. Endocr Pathol. 1996. PMID: 12114736 - Regulation of gonadotropin gene expression by Mullerian inhibiting substance.
Bédécarrats GY, O'Neill FH, Norwitz ER, Kaiser UB, Teixeira J. Bédécarrats GY, et al. Proc Natl Acad Sci U S A. 2003 Aug 5;100(16):9348-53. doi: 10.1073/pnas.1633592100. Epub 2003 Jul 23. Proc Natl Acad Sci U S A. 2003. PMID: 12878721 Free PMC article. - Molecular Aspects and Clinical Relevance of GDF9 and BMP15 in Ovarian Function.
Belli M, Shimasaki S. Belli M, et al. Vitam Horm. 2018;107:317-348. doi: 10.1016/bs.vh.2017.12.003. Vitam Horm. 2018. PMID: 29544636 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources